IRIS Accounts Production v25.3.0.601 14382442 Board of Directors 1.4.24 31.3.25 31.3.25 0 0 false true false false false true false Ordinary A 0.01000 Ordinary B 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh143824422024-03-31143824422025-03-31143824422024-04-012025-03-31143824422023-03-31143824422023-04-012024-03-31143824422024-03-3114382442ns15:EnglandWales2024-04-012025-03-3114382442ns14:PoundSterling2024-04-012025-03-3114382442ns10:Director12024-04-012025-03-3114382442ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3114382442ns10:SmallEntities2024-04-012025-03-3114382442ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3114382442ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3114382442ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3114382442ns10:FullAccounts2024-04-012025-03-311438244212024-04-012025-03-3114382442ns10:OrdinaryShareClass12024-04-012025-03-3114382442ns10:OrdinaryShareClass22024-04-012025-03-3114382442ns10:Director22024-04-012025-03-3114382442ns10:RegisteredOffice2024-04-012025-03-3114382442ns5:CurrentFinancialInstruments2025-03-3114382442ns5:CurrentFinancialInstruments2024-03-3114382442ns5:ShareCapital2025-03-3114382442ns5:ShareCapital2024-03-3114382442ns5:RetainedEarningsAccumulatedLosses2025-03-3114382442ns5:RetainedEarningsAccumulatedLosses2024-03-3114382442ns5:NetGoodwill2024-04-012025-03-3114382442ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114382442ns5:PlantMachinery2024-04-012025-03-3114382442ns5:FurnitureFittings2024-04-012025-03-3114382442ns5:ComputerEquipment2024-04-012025-03-3114382442ns5:NetGoodwill2024-03-3114382442ns5:NetGoodwill2025-03-3114382442ns5:NetGoodwill2024-03-3114382442ns5:PlantMachinery2024-03-3114382442ns5:FurnitureFittings2024-03-3114382442ns5:ComputerEquipment2024-03-3114382442ns5:PlantMachinery2025-03-3114382442ns5:FurnitureFittings2025-03-3114382442ns5:ComputerEquipment2025-03-3114382442ns5:PlantMachinery2024-03-3114382442ns5:FurnitureFittings2024-03-3114382442ns5:ComputerEquipment2024-03-3114382442ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3114382442ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3114382442ns10:OrdinaryShareClass12025-03-3114382442ns10:OrdinaryShareClass22025-03-3114382442ns5:RetainedEarningsAccumulatedLosses2024-03-3114382442ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-3114382442ns10:Director112024-03-3114382442ns10:Director112023-03-3114382442ns10:Director112024-04-012025-03-3114382442ns10:Director112023-04-012024-03-3114382442ns10:Director112025-03-3114382442ns10:Director112024-03-31143824422ns10:Director22024-03-31143824422ns10:Director22023-03-31143824422ns10:Director22024-04-012025-03-31143824422ns10:Director22023-04-012024-03-31143824422ns10:Director22025-03-31143824422ns10:Director22024-03-31
REGISTERED NUMBER: 14382442 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Hartley Medical Limited

Hartley Medical Limited (Registered number: 14382442)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Hartley Medical Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: Dr M B C Hartley
Dr A S Lapraik





REGISTERED OFFICE: Solent House
107A Alma Road
Southampton
SO14 6UY





REGISTERED NUMBER: 14382442 (England and Wales)





ACCOUNTANTS: Thomas Croft Limited
Accountants And Taxation Consultants
Solent House
107a Alma Road
Portswood
Southampton
Hampshire
SO14 6UY

Hartley Medical Limited (Registered number: 14382442)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 6,000 8,400
Tangible assets 5 4,294 2,339
10,294 10,739

CURRENT ASSETS
Debtors 6 40,710 36,279
Cash at bank 17,587 16,791
58,297 53,070
CREDITORS
Amounts falling due within one year 7 26,282 20,902
NET CURRENT ASSETS 32,015 32,168
TOTAL ASSETS LESS CURRENT
LIABILITIES

42,309

42,907

CAPITAL AND RESERVES
Called up share capital 8 2 2
Retained earnings 9 42,307 42,905
SHAREHOLDERS' FUNDS 42,309 42,907

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Hartley Medical Limited (Registered number: 14382442)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 December 2025 and were signed on its behalf by:





Dr M B C Hartley - Director


Hartley Medical Limited (Registered number: 14382442)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Hartley Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

Hartley Medical Limited (Registered number: 14382442)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 12,000
AMORTISATION
At 1 April 2024 3,600
Amortisation for year 2,400
At 31 March 2025 6,000
NET BOOK VALUE
At 31 March 2025 6,000
At 31 March 2024 8,400

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2024 1,099 200 2,940 4,239
Additions - - 3,648 3,648
At 31 March 2025 1,099 200 6,588 7,887
DEPRECIATION
At 1 April 2024 46 88 1,766 1,900
Charge for year 263 28 1,402 1,693
At 31 March 2025 309 116 3,168 3,593
NET BOOK VALUE
At 31 March 2025 790 84 3,420 4,294
At 31 March 2024 1,053 112 1,174 2,339

Hartley Medical Limited (Registered number: 14382442)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 3,113 12,642
Other debtors 37,597 23,637
40,710 36,279

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Corporation tax 15,988 16,826
Directors' current accounts 9,047 2,876
Accrued expenses 1,247 1,200
26,282 20,902

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
100 Ordinary A £0.01 1 1
100 Ordinary B £0.01 1 1
2 2

9. RESERVES
Retained
earnings
£   

At 1 April 2024 42,905
Profit for the year 57,902
Dividends (58,500 )
At 31 March 2025 42,307

Hartley Medical Limited (Registered number: 14382442)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
Dr M B C Hartley
Balance outstanding at start of year (2,876 ) (18,616 )
Amounts advanced - 18,616
Amounts repaid (6,170 ) (2,876 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (9,046 ) (2,876 )

Dr A S Lapraik
Balance outstanding at start of year - 1
Amounts repaid - (1 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

11. RELATED PARTY DISCLOSURES

During the year, total dividends of £58,500 were paid to the directors .

The company was under the control of Dr M Hartley and Dr A Lapraik throughout the current period. Dr M Hartley and Dr A Lapraik are the managing directors and majority shareholders.

The company is a member of Trinity Medicolegal LLP (OC444937) and received £70,275 (2024: £50,422) during the year. The investment in the Trinity Medicolegal LLP is carred on the balance sheet at £37,597 (2024: £23,636).